Enanta Pharmaceuticals

Enanta Pharmaceuticals ENTA Stock

$8.23   -5.293442%
Add to favorites
Market Cap
$239.70M
LOW - HIGH [24H]
$8.10 - $8.75
VOLUME [24H]
$811.55K
P/E Ratio
0
Earnings per share
-$2.35
ISIN
US29251M1062
Price   Prediction

Enanta Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

Enanta Pharmaceuticals (ENTA) stock price today is 8.23 USD on Tech Market Large (-5.29% on the day). Updated .

Enanta Pharmaceuticals ENTA Financial and Trading Overview

Enanta Pharmaceuticals stock price 8.23 USD
Previous Close 8.69 USD
Open 8.47 USD
Bid 6.12 USD x 200
Ask 10.54 USD x 200
Day's Range 8.18 - 8.75 USD
52 Week Range 8.18 - 17.15 USD
Volume 212.36K USD
Avg. Volume 271.42K USD
Market Cap 242.47M USD
Beta (5Y Monthly) 0.762
PE Ratio (TTM) N/A
EPS (TTM) -2.35 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 21.83 USD

ENTA Valuation Measures

Enterprise Value 236.25M USD
Trailing P/E N/A
Forward P/E -3.663366
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.8486526
Price/Book (mrq) 3.0239737
Enterprise Value/Revenue 3.75
Enterprise Value/EBITDA -4.105

Trading Information

Enanta Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.762
52-Week Change -28.35%
S&P500 52-Week Change 10.51%
52 Week High 17.15 USD
52 Week Low 8.18 USD
50-Day Moving Average 11.78 USD
200-Day Moving Average 13.06 USD

ENTA Share Statistics

Avg. Volume (3 month) 271.42K USD
Avg. Daily Volume (10-Days) 321.7K USD
Shares Outstanding 29.13M
Float 22.52M
Short Ratio 7.01
% Held by Insiders 4.67%
% Held by Institutions 91.49%
Shares Short 1.86M
Short % of Float 7.63%
Short % of Shares Outstanding 6.37%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2026
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End September 30, 2027

Profitability

Profit Margin -108.32%
Operating Margin (ttm) -99.013%
Gross Margin 100.00%
EBITDA Margin -91.34%

Management Effectiveness

Return on Assets (ttm) -14.016%
Return on Equity (ttm) -94.19%

Income Statement

Revenue (ttm) 63M USD
Revenue Per Share (ttm) 2.17 USD
Quarterly Revenue Growth (yoy) -14.89%
Gross Profit (ttm) 63M USD
EBITDA -57548000 USD
Net Income Avi to Common (ttm) -68248000 USD
Diluted EPS (ttm) -2.35
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 194.51M USD
Total Cash Per Share (mrq) 6.68 USD
Total Debt (mrq) 177.65M USD
Total Debt/Equity (mrq) 221.53 USD
Current Ratio (mrq) 3.782
Book Value Per Share (mrq) 2.753

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Enanta Pharmaceuticals

Country United States
State MA
City Watertown
Address 4 Kingsbury Avenue
ZIP 02472
Phone 617 607 0800
Website https://www.enanta.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Q&A For Enanta Pharmaceuticals Stock

What is a current ENTA stock price?

Enanta Pharmaceuticals ENTA stock price today per share is 8.23 USD.

How to purchase Enanta Pharmaceuticals stock?

You can buy ENTA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Enanta Pharmaceuticals?

The stock symbol or ticker of Enanta Pharmaceuticals is ENTA.

Which industry does the Enanta Pharmaceuticals company belong to?

The Enanta Pharmaceuticals industry is Biotechnology.

How many shares does Enanta Pharmaceuticals have in circulation?

The max supply of Enanta Pharmaceuticals shares is 29.13M.

What is Enanta Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Enanta Pharmaceuticals PE Ratio is now.

What was Enanta Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Enanta Pharmaceuticals EPS is -2.35 USD over the trailing 12 months.

Which sector does the Enanta Pharmaceuticals company belong to?

The Enanta Pharmaceuticals sector is Healthcare.

Enanta Pharmaceuticals ENTA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.15B USD — 24225.3 USD — 24538.78 USD — — 7.15B USD —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
us US Tech Composite Total Return XCMP US 30190.38 USD —
+0.42
— — 29937.56 USD — 30324.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Biotechnology Total Retu XNBI US 7618.1 USD —
-0.66
— — 7605.28 USD — 7732.54 USD — — — —
us US Tech Global Select Market Com NQGS US 12034.87 USD —
+0.42
— — 11933.12 USD — 12087.81 USD — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
$2.16T
Total marketcap
$70.34B
Total volume
BTC 58.03%   •   ETH 9.95%
Dominance
Select currency